These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
650 related articles for article (PubMed ID: 26386561)
1. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas. Jang BG; Lee BL; Kim WH Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561 [TBL] [Abstract][Full Text] [Related]
2. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer. Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864 [TBL] [Abstract][Full Text] [Related]
3. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999 [TBL] [Abstract][Full Text] [Related]
4. Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients. Altan B; Yokobori T; Ide M; Mochiki E; Toyomasu Y; Kogure N; Kimura A; Hara K; Bai T; Bao P; Suzuki M; Ogata K; Asao T; Nishiyama M; Oyama T; Kuwano H Gastric Cancer; 2016 Jul; 19(3):789-97. PubMed ID: 26472729 [TBL] [Abstract][Full Text] [Related]
5. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer. Stanisavljević L; Myklebust MP; Leh S; Dahl O Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662 [TBL] [Abstract][Full Text] [Related]
6. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients. Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987 [TBL] [Abstract][Full Text] [Related]
7. Distribution of Lgr5-positive cancer cells in intramucosal gastric signet-ring cell carcinoma. Nakajima T; Uehara T; Maruyama Y; Iwaya M; Kobayashi Y; Ota H Pathol Int; 2016 Sep; 66(9):518-23. PubMed ID: 27593551 [TBL] [Abstract][Full Text] [Related]
8. The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer. Hyun CL; Park SJ; Kim HS; Song HJ; Kim HU; Lee C; Lee DH; Maeng YH; Kim YS; Jang B Anticancer Res; 2021 Jul; 41(7):3689-3698. PubMed ID: 34230168 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy. Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367 [TBL] [Abstract][Full Text] [Related]
10. TPX2 expression is associated with poor survival in gastric cancer. Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036 [TBL] [Abstract][Full Text] [Related]
11. Expression profile of intestinal stem cell and cancer stem cell markers in gastric cancers with submucosal invasion. Kim HS; Song HJ; Kim HU; Jeong IH; Koh HM; Shin JH; Jang BG Pathol Res Pract; 2021 Feb; 218():153336. PubMed ID: 33450435 [TBL] [Abstract][Full Text] [Related]
12. Expression of LGR5, FZD7, TROY, and MIST1 in Perioperatively Treated Gastric Carcinomas and Correlation with Therapy Response. Freiin Grote A; Halske C; Behrens HM; Krüger S; Wilhelm F; Egberts JH; Röcken C Dis Markers; 2019; 2019():8154926. PubMed ID: 31827644 [TBL] [Abstract][Full Text] [Related]
13. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis. Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1. Wang LL; Wang L; Wang XY; Shang D; Yin SJ; Sun LL; Ji HB Tumour Biol; 2016 Nov; 37(11):15241-15252. PubMed ID: 27696291 [TBL] [Abstract][Full Text] [Related]
15. Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer. Xi HQ; Cai AZ; Wu XS; Cui JX; Shen WS; Bian SB; Wang N; Li JY; Lu CR; Song Z; Wei B; Chen L Br J Cancer; 2014 Apr; 110(8):2011-20. PubMed ID: 24594994 [TBL] [Abstract][Full Text] [Related]
16. Beclin 1 expression is an independent prognostic factor for gastric carcinomas. Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926 [TBL] [Abstract][Full Text] [Related]
17. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer. Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898 [TBL] [Abstract][Full Text] [Related]
18. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1. Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430 [TBL] [Abstract][Full Text] [Related]
19. Intestinal Stem Cell Markers in the Intestinal Metaplasia of Stomach and Barrett's Esophagus. Jang BG; Lee BL; Kim WH PLoS One; 2015; 10(5):e0127300. PubMed ID: 25996368 [TBL] [Abstract][Full Text] [Related]
20. Reduced expression and homozygous deletion of annexin A10 in gastric carcinoma. Kim J; Kim MA; Jee CD; Jung EJ; Kim WH Int J Cancer; 2009 Oct; 125(8):1842-50. PubMed ID: 19582876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]